BIO Online Learning

Through a curated network of education alliance partners, BIO offers industry professionals executive training and development resources for accelerating career growth

Recorded BioBasics 201: Targeted Biologics for the Non-Scientist Master Course

This is the recorded BioBasics 201 course which has the same content, interactive exercises, and course materials that are given in the live version. You have 3 months to view this course. 

BioBasics 201: Targeted Biologics for the Non-Scientist is an intensive course specifically designed for graduates of BioBasics 101 or learners who understand fundamental biopharma industry science. The inspiration for targeted biologics is our own immune system, so the course begins with an in-depth explanation of immunology. It next includes a discussion of immunotherapies, vaccines, cell therapies, regenerative medicines, gene therapies, and RNA-based drugs. Join us and enhance your fluency in the science, development challenges, and medical potential of targeted biologics.  This is a recording of a BioBasics 201 course given live.

BIO members receive a $100 discount. BIO members should use the code BIO100 to register for this course.

Takeaways

  • Rationale behind cancer immunotherapies
  • Challenges and second-generation opportunities for immunotherapies
  • Differentiation between the types of DNA- and RNA-based therapies
  • Improved understanding of gene therapy and genome editing
  • Ability to discuss multiple applications of genome editing

Download Course Syllabus

Recorded BioBasics 201: Targeted Biologics for the Non-Scientist
Course Price:
$795 USD
BIO Member Price:
$695 USD
Course Length:
10 hours
Course Level:
Introductory
Completion Period:
3 months
Course Format:
On-Demand

Certificate Requirements

  • View all videos
  • Read all articles
  • Complete course evaluation
Suggested Prerequisites
FLIP

Learn the science driving the biopharma industry.

Professional Certificate
Related Courses
FLIP

Learn about the science driving today’s hottest biopharma innovations including therapeutic antibodies, novel vaccines, gene therapy, and immunotherapies.

FLIP

Explore a process for developing a strategy along with a tactical game plan for launching a Global Fundraising Campaign...

FLIP

Gain a systematic approach to producing a valuation that can be used in investment rounds, mergers/acquisitions, licensing deals or strategic development decisions in the pharma-biotech world...

FLIP

Explore a broad range of issues faced by entrepreneurs from the managerial, scientific, and academic communities...